Teladoc Health, Inc.

TDOC

US87918A1051

Healthcare Facilities & Services

Real-time Estimate Cboe BZX Other stock markets 03:07:08 2024-04-25 pm EDT			5-day change	1st Jan Change
13.4 ^USD	-2.37%		+1.40%	-37.98%

Apr. 12	Teladoc Health, Inc. Announces Resignation of Richard J. Napolitano as Chief Accounting Officer, Effective May 3, 2024	CI
Apr. 08	Deutsche Bank Cuts Teladoc's Price Target to $18 From $22, Maintains Hold Rating	MT

Teladoc Health, Inc. Provides Revenue Guidance for the Year Ending December 31, 2021

January 10, 2022 at 08:00 am EST

Teladoc Health, Inc. provided revenue guidance for the year ending December 31, 2021. For the period, the company expects total revenue to be approximately $2,030 million.

Latest news about Teladoc Health, Inc.

Teladoc Health, Inc. Announces Resignation of Richard J. Napolitano as Chief Accounting Officer, Effective May 3, 2024	Apr. 12	CI
Deutsche Bank Cuts Teladoc's Price Target to $18 From $22, Maintains Hold Rating	Apr. 08	MT
Teladoc Chief Executive Leaves, Chief Financial Officer Mala Murthy Named Acting CEO	Apr. 05	MT
Teladoc Health, Inc. Announces Chief Executive Officer Changes	Apr. 05	CI
Teladoc Health Seeks M&A	Mar. 13	CI
Transcript : Teladoc Health, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 09:30 AM	Mar. 13
Sector Update: Health Care Stocks Gain Late Afternoon	Mar. 07	MT
Sector Update: Health Care Stocks Stronger in Afternoon Trading	Mar. 07	MT
Teladoc Expands Obesity, Weight-Management Offering; Shares Rise	Mar. 07	MT
Teladoc Health Insider Sold Shares Worth $266,354, According to a Recent SEC Filing	Mar. 05	MT
Teladoc Health Insider Sold Shares Worth $433,854, According to a Recent SEC Filing	Mar. 05	MT
Transcript : Teladoc Health, Inc. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 02:50 PM	Mar. 04
Leerink Partners Initiates Coverage on Teladoc With Market Perform Rating, $17 Price Target	Feb. 26	MT
Deutsche Bank Adjusts Teladoc Price Target to $22 From $23, Maintains Hold Rating	Feb. 22	MT
Health Care Down on a Mixed Growth View -- Health Care Roundup	Feb. 21	DJ
Sector Update: Health Care Stocks Mixed in Late Afternoon	Feb. 21	MT
Sector Update: Health Care Stocks Slipping Wednesday Afternoon	Feb. 21	MT
Citigroup Adjusts Teladoc Price Target to $19 From $21, Maintains Neutral Rating	Feb. 21	MT
Teladoc Shares Fall After Q4 Results, Guidance	Feb. 21	MT
Barclays Trims Price Target on Teladoc to $25 From $26, Maintains Overweight Rating	Feb. 21	MT
Canaccord Genuity Lowers Price Target on Teladoc to $28 From $34, Maintains Buy Rating	Feb. 21	MT
Piper Sandler Adjusts Price Target on Teladoc to $25 From $30, Maintains Overweight Rating	Feb. 21	MT
Traders Await Fed Minutes, Nvidia Earnings as US Equity Futures Drop Pre-Bell	Feb. 21	MT
RBC Cuts Price Target on Teladoc to $25 From $30, Notes 'Slower Expected Revenue Trajectory,' Keeps Outperform Rating	Feb. 21	MT
North American Morning Briefing : Stock Futures Fall With Nvidia Results, Fed Minutes Eyed	Feb. 21	DJ

Teladoc Health, Inc. provides virtual healthcare services. The Company operates through two segments: Teladoc Health Integrated Care (Integrated Care) and BetterHelp. The Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed primarily on a business-to-business (B2B) basis. The BetterHelp segment primarily consists of its direct-to-consumer (D2C) mental health platform. The online counseling and therapy services are provided via its network of over 40,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs.

Sector

Healthcare Facilities & Services

Calendar

04:05pm - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Teladoc Health, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

13.73 USD

Average target price

19.51 USD

Spread / Average Target

+42.12%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Telemedicine Services

	1st Jan change	Capi.
TELADOC HEALTH, INC.	-37.98%	2.32B
TALKSPACE, INC.	+21.16%	519M
QDM INTERNATIONAL INC.	+42.77%	467M
AMERICAN WELL CORPORATION	-64.11%	158M
SHL TELEMEDICINE LTD.	-30.22%	86.98M

Telemedicine Services